| CAT No: | CL-ESMD-04 |
| CAS No: | NA |
| Mol.F: | C26H26F3NO5 |
| Mol.Wt.: | 489.5 |
| Rel. Cas No: | |
| Chemical Name: | 2-(8-((4-Cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-2,6-dioxo-1,2,3,4,5,6-hexahydrobenzo[b]azocin-3-yl)acetic acid |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Etrasimod Impurity 16 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Etrasimod Impurity 16 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-(8-((4-Cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-2,6-dioxo-1,2,3,4,5,6-hexahydrobenzo[b]azocin-3-yl)acetic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Etrasimod Molecular Formula: C26H26F3NO5
Molecular Weight: 489.5
Storage: Store in a cool, dry place.
| Product Name: | Etrasimod Impurity 16 |
| CAS No: | |
| Mol.F.: | C26H26F3NO5 |
| Mol.Wt.: | 489.5 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: